Cite Filings / ELVN / 0000950170-24-059573

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Enliven Therapeutics, Inc. Filed 2024-05-14 Acc 0000950170-24-059573

Documents 1

10-Q Quarterly Report , elvn-20240331.htm

Around this filing

2024-08-13 10-Q Quarterly Report
2024-05-16 144 Sale of Securities
2024-05-16 4 CHIEF OPERATING OFFICER sold 1,107 shares at $25.00 ($27,675)
2024-05-14 10-Q Quarterly Report
2024-05-14 8-K Results of operations
2024-05-13 4 CHIEF OPERATING OFFICER sold 260 shares at $25.06 ($6,515)
2023-11-09 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading elvn-20240331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…